![Hakim Bouterfa](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Hakim Bouterfa
Private Equity Investor chez
1717 Life Sciences Ventures GmbH
Profil
Hakim Larbi Bouterfa is the founder of OctreoPharm Sciences GmbH, founded in 2009.
Dr. Bouterfa is also the founder of PentixaPharm GmbH.
Currently, Dr. Bouterfa is the Managing Partner at 1717 Life Sciences Ventures GmbH since 2017.
Formerly, Dr. Bouterfa was Medical Director-Sandostatin Franchise at Novartis Pharma GmbH, Managing Director & VP-European Operations at Molecular Insight Pharmaceuticals GmbH, Chief Medical Officer at Eckert & Ziegler SE in 2023, and Member of the Supervisory Board at Pentixapharm Holding AG from 2024 to 2025.
Postes actifs de Hakim Bouterfa
| Sociétés | Poste | Début |
|---|---|---|
1717 Life Sciences Ventures GmbH
 1717 Life Sciences Ventures GmbH Investment ManagersFinance Acts as an alternative investment manager | Private Equity Investor | 01/01/2017 |
Anciens postes connus de Hakim Bouterfa
| Sociétés | Poste | Fin |
|---|---|---|
PentixaPharm GmbH
 PentixaPharm GmbH BiotechnologyHealth Technology Operates as a clinical-stage biotech company that discovers and develops novel targeted radiopharmaceuticals | Directeur Général | 27/10/2024 |
| ECKERT & ZIEGLER SE | Directeur Technique/Scientifique/R&D | 31/12/2023 |
Novartis Pharma GmbH
 Novartis Pharma GmbH Pharmaceuticals: MajorHealth Technology Manufactures and sells pharmaceutical products | Corporate Officer/Principal | - |
Molecular Insight Pharmaceuticals GmbH
 Molecular Insight Pharmaceuticals GmbH Pharmaceuticals: MajorHealth Technology Develops and commercializes innovative molecular imaging pharmaceuticals | Directeur Général | - |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
1
Relations au 1er degré
6
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 6 |
|---|---|
Eckert & Ziegler Strahlen- und Medizintechnik AG
 Eckert & Ziegler Strahlen- und Medizintechnik AG Medical SpecialtiesHealth Technology Provides isotope technology for medical, scientific and industrial use | Health Technology |
Novartis Pharma GmbH
Novartis Pharma GmbH Pharmaceuticals: MajorHealth Technology Manufactures and sells pharmaceutical products | Health Technology |
OctreoPharm Sciences GmbH
 OctreoPharm Sciences GmbH Pharmaceuticals: MajorHealth Technology Develops and manufactures pharmaceutical products | Health Technology |
Molecular Insight Pharmaceuticals GmbH
Molecular Insight Pharmaceuticals GmbH Pharmaceuticals: MajorHealth Technology Develops and commercializes innovative molecular imaging pharmaceuticals | Health Technology |
1717 Life Sciences Ventures GmbH
1717 Life Sciences Ventures GmbH Investment ManagersFinance Acts as an alternative investment manager | Finance |
PentixaPharm GmbH
PentixaPharm GmbH BiotechnologyHealth Technology Operates as a clinical-stage biotech company that discovers and develops novel targeted radiopharmaceuticals | Health Technology |
